Peter Meldgaard

5.0k total citations
92 papers, 2.3k citations indexed

About

Peter Meldgaard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Peter Meldgaard has authored 92 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Peter Meldgaard's work include Lung Cancer Treatments and Mutations (56 papers), Lung Cancer Diagnosis and Treatment (31 papers) and Cancer Genomics and Diagnostics (26 papers). Peter Meldgaard is often cited by papers focused on Lung Cancer Treatments and Mutations (56 papers), Lung Cancer Diagnosis and Treatment (31 papers) and Cancer Genomics and Diagnostics (26 papers). Peter Meldgaard collaborates with scholars based in Denmark, United Kingdom and United States. Peter Meldgaard's co-authors include Boe Sandahl Sørensen, Britta Weber, Ebba Nexø, Birgitte Sandfeld‐Paulsen, Torben Riis Rasmussen, Kristine Raaby Jakobsen, Lars Fokdal, Birgitte Holst Folkersen, Rikke Bæk and Kim Varming and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Peter Meldgaard

89 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Meldgaard Denmark 23 1.1k 890 888 858 259 92 2.3k
Ignacio Gil‐Bazo Spain 31 1.0k 0.9× 1.1k 1.3× 805 0.9× 1.2k 1.4× 154 0.6× 103 2.6k
John C. English Canada 30 1.2k 1.1× 688 0.8× 401 0.5× 737 0.9× 188 0.7× 79 2.6k
Saiama N. Waqar United States 29 1.9k 1.7× 1.7k 2.0× 551 0.6× 654 0.8× 292 1.1× 143 2.9k
J. Doyen France 22 661 0.6× 716 0.8× 617 0.7× 520 0.6× 211 0.8× 101 1.9k
Alana Christie United States 27 1.5k 1.4× 694 0.8× 640 0.7× 930 1.1× 227 0.9× 145 2.6k
Anna M. Varghese United States 24 1.0k 0.9× 1.8k 2.0× 696 0.8× 689 0.8× 151 0.6× 111 2.6k
Matteo Giaj Levra France 18 2.3k 2.0× 1.9k 2.1× 598 0.7× 599 0.7× 236 0.9× 70 3.0k
Sacha I. Rothschild Switzerland 29 839 0.8× 1.4k 1.6× 585 0.7× 845 1.0× 182 0.7× 128 2.6k
Flavia Longo Italy 26 910 0.8× 998 1.1× 417 0.5× 390 0.5× 226 0.9× 71 2.0k
Thomas Gauler Germany 30 1.7k 1.6× 1.6k 1.8× 481 0.5× 797 0.9× 560 2.2× 152 3.1k

Countries citing papers authored by Peter Meldgaard

Since Specialization
Citations

This map shows the geographic impact of Peter Meldgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Meldgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Meldgaard more than expected).

Fields of papers citing papers by Peter Meldgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Meldgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Meldgaard. The network helps show where Peter Meldgaard may publish in the future.

Co-authorship network of co-authors of Peter Meldgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Meldgaard. A scholar is included among the top collaborators of Peter Meldgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Meldgaard. Peter Meldgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greibe, Eva, Boe Sandahl Sørensen, Peter Meldgaard, & Elke Hoffmann. (2025). Development and validation of an LC-MS/MS method for quantification of Osimertinib and its two metabolites AZ7550 and AZ5104 in human plasma including long-time storage. Journal of Pharmaceutical and Biomedical Analysis. 255. 116662–116662. 2 indexed citations
2.
3.
Meldgaard, Peter, et al.. (2024). Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies. International Journal of Molecular Sciences. 25(2). 1243–1243. 5 indexed citations
4.
Ording, Anne Gulbech, Thomas Decker Christensen, Flemming Skjøth, et al.. (2024). Risk of Venous Thromboembolism in Patients With Stage III and IV Non–Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study. Clinical Lung Cancer. 25(5). 407–416.e1. 4 indexed citations
5.
6.
7.
Meldgaard, Peter, et al.. (2023). Diagnostic accuracy of the geriatric screening tools G8 and modified G8 in older patients with lung cancer: A diagnostic performance study. Journal of Geriatric Oncology. 15(2). 101645–101645. 1 indexed citations
8.
Stougaard, Magnus, et al.. (2022). Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy. Journal of Clinical Pathology. 77(1). 54–60. 4 indexed citations
9.
Meldgaard, Peter, et al.. (2021). Co-occurring MET Amplification Predicts Inferior Clinical Response to First-Line Erlotinib in Advanced Stage EGFR-Mutated NSCLC Patients. Clinical Lung Cancer. 22(6). e870–e877. 9 indexed citations
10.
Winther‐Larsen, Anne, Claus Vinter Bødker Hviid, Peter Meldgaard, Boe Sandahl Sørensen, & Birgitte Sandfeld‐Paulsen. (2020). Neurofilament Light Chain as A Biomarker for Brain Metastases. Cancers. 12(10). 2852–2852. 25 indexed citations
11.
Poehl, Mette, Morten Ladekarl, Peter Meldgaard, et al.. (2020). 1334P Real word experience with first-line immunotherapy in advanced non-small cell lung cancer patients in a Danish nationwide cohort. Annals of Oncology. 31. S858–S858. 1 indexed citations
12.
Gregersen, Merete, Anni Ravnsbæk Jensen, Kenneth Jensen, et al.. (2020). The impact of a tailored follow-up intervention on comprehensive geriatric assessment in older patients with cancer - a randomised controlled trial. Journal of Geriatric Oncology. 12(1). 41–48. 20 indexed citations
13.
Østrup, Oľga, Boe Sandahl Sørensen, Peter Meldgaard, et al.. (2019). Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy: A Randomized Controlled Trial (SUPER). Clinical Lung Cancer. 21(2). e61–e64. 3 indexed citations
14.
Daugaard, Tina Fuglsang, et al.. (2018). Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC. Translational Oncology. 12(3). 432–440. 21 indexed citations
15.
Cho, Jong Ho, Yoon‐La Choi, Yu Feng, et al.. (2017). Programmed Death Ligand 1 Expression in Paired Non–Small Cell Lung Cancer Tumor Samples. Clinical Lung Cancer. 18(6). e473–e479. 32 indexed citations
16.
Sandfeld‐Paulsen, Birgitte, Peter Meldgaard, & Ninna Aggerholm‐Pedersen. (2017). Comorbidity in Lung Cancer: A Prospective Cohort Study of Self-Reported versus Register-Based Comorbidity. Journal of Thoracic Oncology. 13(1). 54–62. 20 indexed citations
17.
Sandfeld‐Paulsen, Birgitte, Birgitte Holst Folkersen, Torben Riis Rasmussen, Peter Meldgaard, & Boe Sandahl Sørensen. (2016). Gene Expression of the EGF System—a Prognostic Model in Non–Small Cell Lung Cancer Patients Without Activating EGFR Mutations. Translational Oncology. 9(4). 306–312. 7 indexed citations
18.
Weber, Britta, Boe Sandahl Sørensen, Marianne Marquard Knap, et al.. (2011). Complete Pathologic Response in Lung Tumors in Two Patients with Metastatic Non-small Cell Lung Cancer Treated with Erlotinib. Journal of Thoracic Oncology. 6(11). 1946–1949. 10 indexed citations
19.
James, R.D., Sandro Barni, Ludwig Fischer von Weikersthal, et al.. (2010). Improving chemotherapy capacity by switching from i.v. to oral vinorelbine. University of Southern Denmark Research Portal (University of Southern Denmark). 4. 14–18. 5 indexed citations
20.
Fokdal, Lars, Morten Høyer, Peter Meldgaard, & Hans von der Maase. (2004). Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiotherapy and Oncology. 72(2). 139–145. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignacio Gil‐Bazo Breakdown of academic impact, for papers by John C. English Breakdown of academic impact, for papers by Saiama N. Waqar Breakdown of academic impact, for papers by J. Doyen Breakdown of academic impact, for papers by Alana Christie Breakdown of academic impact, for papers by Anna M. Varghese Breakdown of academic impact, for papers by Matteo Giaj Levra Breakdown of academic impact, for papers by Sacha I. Rothschild Breakdown of academic impact, for papers by Flavia Longo Breakdown of academic impact, for papers by Thomas Gauler
Rankless by CCL
2026